In last trading session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw 0.85 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) has a beta value of 0.35 and has seen 1.11 million shares traded in the last trading session. The company, currently
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.34. At the close of
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 1.12 million during the last session, with the company’s beta value hitting 0.34. At the close of
In the last trading session, 1.03 million ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) shares changed hands as the company’s beta touched 0.20. With the company’s per share
In last trading session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw 1.19 million shares changing hands with its beta currently measuring 0.20. Company’s recent per share price
In recent trading session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw 0.29 million shares changing hands at last check today with its beta currently measuring 0.20. Company’s
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) has a beta value of 0.25 and has seen 4.31 million shares traded in the last trading session. The company, currently
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) has a beta value of 0.27 and has seen 3.85 million shares traded in the last trading session. The company, currently
During the last session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares were 327.07 million, with the beta value of the company hitting 0.21. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
